PATENT CLAIM ANALYSIS

Application Number: 16157653
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "635000"]

Abstract:
Methods of treating developmental disorders such as Angelman syndrome, Fragile X syndrome, Fragile X-associated tremor/ataxia syndrome (FXTAS), Autistic Spectrum Disorder, Autism, Asperger's syndrome, pervasive developmental disorder, Childhood Disintegrative Disorder, Rett syndrome, Landau-Kleffner Syndrome, Prader-Willi Syndrome, Tardive Dyskinesia, a seizure disorder and/or Williams Syndrome with a biguanide such as metformin, buformin, phenformin or a pharmaceutically acceptable salt thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder.

Claim (Index 20):
The method of  claim 14 , wherein the composition is an immediate release dosage form.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.49231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15680417', '15961002', '15191068', '15002531', '15707239']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8004169386454333
- 35 USC 102 Novelty (BERT): 0.5688658841577047
- Combined Prediction Score: 0.7772618331966604
- Mean Citation Score: 342.173376
- Max Citation Score: 566.11414
- Similarity Product: 312.413912945199

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test